SG10202111437XA - Cyclic plasmenylethanolamines - Google Patents

Cyclic plasmenylethanolamines

Info

Publication number
SG10202111437XA
SG10202111437XA SG10202111437XA SG10202111437XA SG10202111437XA SG 10202111437X A SG10202111437X A SG 10202111437XA SG 10202111437X A SG10202111437X A SG 10202111437XA SG 10202111437X A SG10202111437X A SG 10202111437XA SG 10202111437X A SG10202111437X A SG 10202111437XA
Authority
SG
Singapore
Prior art keywords
plasmenylethanolamines
cyclic
cyclic plasmenylethanolamines
Prior art date
Application number
SG10202111437XA
Inventor
Tara Smith
Original Assignee
Med Life Discoveries Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Med Life Discoveries Lp filed Critical Med Life Discoveries Lp
Publication of SG10202111437XA publication Critical patent/SG10202111437XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65844Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a five-membered ring which may be condensed with another ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10202111437XA 2017-04-17 2018-03-12 Cyclic plasmenylethanolamines SG10202111437XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762486037P 2017-04-17 2017-04-17

Publications (1)

Publication Number Publication Date
SG10202111437XA true SG10202111437XA (en) 2021-11-29

Family

ID=63856201

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202111437XA SG10202111437XA (en) 2017-04-17 2018-03-12 Cyclic plasmenylethanolamines
SG11201908364Y SG11201908364YA (en) 2017-04-17 2018-03-12 Cyclic plasmenylethanolamines

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201908364Y SG11201908364YA (en) 2017-04-17 2018-03-12 Cyclic plasmenylethanolamines

Country Status (8)

Country Link
US (1) US11311560B2 (en)
EP (1) EP3612541A4 (en)
JP (2) JP7161781B2 (en)
CN (1) CN110621683B (en)
AU (2) AU2018255514A1 (en)
CA (1) CA3056148A1 (en)
SG (2) SG10202111437XA (en)
WO (1) WO2018191812A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101675337A (en) * 2007-04-13 2010-03-17 菲诺梅诺米发现公司 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
WO2012039472A1 (en) * 2010-09-24 2012-03-29 医療法人社団ブックス Drug against central nervous system inflammation
JP5997887B2 (en) * 2011-09-05 2016-09-28 学校法人帝京大学 Oral administration
WO2013071412A1 (en) * 2011-11-17 2013-05-23 Phenomenome Discoveries Inc. Methods for the synthesis of 13c labeled plasmalogen
US9169280B2 (en) * 2011-11-17 2015-10-27 Phenomenome Discoveries Inc. Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof
CN105646587B (en) * 2016-03-02 2018-03-23 云南中医学院 1,3,2 oxynitride phosphor Polymorphs alkyl compounds, preparation method and application

Also Published As

Publication number Publication date
EP3612541A4 (en) 2020-12-23
AU2022283770A1 (en) 2023-02-02
JP2022188235A (en) 2022-12-20
CA3056148A1 (en) 2018-10-25
US20210128590A1 (en) 2021-05-06
CN110621683B (en) 2023-02-17
AU2018255514A1 (en) 2019-10-17
WO2018191812A1 (en) 2018-10-25
JP7161781B2 (en) 2022-10-27
SG11201908364YA (en) 2019-11-28
CN110621683A (en) 2019-12-27
US11311560B2 (en) 2022-04-26
EP3612541A1 (en) 2020-02-26
AU2022283770B2 (en) 2024-02-29
JP2020516602A (en) 2020-06-11

Similar Documents

Publication Publication Date Title
DK3606954T3 (en) Anti-LAG3-antistoffer
GB201703129D0 (en) Quibbler
DK3734167T3 (en) Airconditionsystem
DK3499914T3 (en) Høreapparatsystem
DK3700925T3 (en) Hidtil ukendt t-cellereceptor
DK3615457T3 (en) Transportcontainer
AU201714106S (en) Mandoline
GB201820521D0 (en) n
EP3684343C0 (en) Improved supraparticles
DK3630041T3 (en) Stimulationsapparat
DK3401557T3 (en) Træskrue
IL272526A (en) Improved endoinulinases
DK3718525T3 (en) Motoriseret asssistancesystem
DK3485765T3 (en) Computerbord
GB201701986D0 (en) n
GB201700825D0 (en) Poliovaccine
DK3704866T3 (en) Datatransmissionssystem
GB201813378D0 (en) n
GB201707210D0 (en) Improved hitchlock
GB201702641D0 (en) Easpagnolette
SG10202111437XA (en) Cyclic plasmenylethanolamines
DK3425793T3 (en) Tagsystem
DK3618761T3 (en) Intrakorporalt perfusionssystem
DK3351149T3 (en) Syltetøjsfontæne
AU201715236S (en) Striplight